From initial diagnosis and all along a prostate cancer journey, PHENPath supports patients in making informed and shared-decisions with their doctors.
Visit us today to choose a pathway based on your diagnosis.
PHENPath helps prostate cancer patients to understand their treatment pathways and treatment options.
— PHENPath.com helps Prostate Cancer patients understand their treatment pathways and treatment options. Prostate Cancer diagnosis, Treatment Options, PSA Recurrence after Radical Prostatectomy, Progression After Radiation, Hormone Sensitive Cancer, Castration Resistent Cancer, Low Risk, Very Low Risk, Intermediate Risk, High Risk, Very High Risk, Metastatic, Regional, Prostate Cancer Diagnosis, Testing, Treatment Therapies, Understanding your Risk Level
Recent Posts
The Jackson, Mississippi Prostate Cancer Disparity Rally mobilized leaders to record prostate cancer awareness messages.
PHENPath.com – Empowering Patients
PHEN Supports Talapro-3 Clinical Trial
The FDA approves a new prostate cancer combination treatment based upon a successful clinical trial- If you are experiencing PSA recurrence after surgery, PHENPath.com provides information about available treatment options as set forth by NCCN Guidelines®
